Roussel, R., Darmon, P., Pichelin, M., Goronflot, T., Abouleka, Y., Ait Bachir, L., Allix, I., Ancelle, D., Barraud, S., Bordier, L., Carlier, A., Chevalier, N., Coffin‐Boutreux, C., Cosson, E., Dorange, A., Dupuy, O., Fontaine, P., Fremy, B., Galtier, F., Germain, N., Guedj, A., Larger, E., Laugier‐Robiolle, S., Laviolle, B., Ludwig, L., Monier, A., Montanier, N., Moulin, P., Moura, I., Prevost, G., Reznik, Y., Sabbah, N., Saulnier, P., Serusclat, P., Vatier, C., Wargny, M., Hadjadj, S., Gourdy, P., Cariou, B., & , (2021). use of dipeptidyl peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study. Diabetes, obesity & metabolism, 23(5), 1162–1172. http://access.bl.uk/ark:/81055/vdc_100127528868.0x00001c